Retrospective analysis of 34 febrile neutropenia episodes - therapeutic implication of multiplex polymerase chain reaction in infection diagnosis
Conclusion: Newer non–culture-based molecular technologies like SES are changing the way we manage FN. It is faster, has a higher diagnostic yield as compared to traditional culture, and helps in making rapid, evidence-based therapeutic decision-making including de-escalation of antimicrobials. It would potentially lead to a reduction in mortality and healthcare cost in the long run.
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Sachin Jadhav Mahesh Rajashekaraiah Dipanjan Chakraborty N Bharath Safeer Ulla Sharieff G Vignesh Keerthi Gandhamaneni Bashwanth Pasupuleti Priya Thomas Jayantha Balawardhana Source Type: research
More News: Antibiotic Therapy | Bone Marrow Transplant | Cancer | Cancer & Oncology | Chemotherapy | India Health | Study | Transplants